EXECUTIVE BOARD
The COBRE Executive Board will closely monitor the progress of the research projects, as well as discuss internal operational concerns, and ensure coordination of research and administrative activities between John A. Burns School of Medicine and other NCRR-sponsored programs. The Board will be responsible for reviewing, responding to and implementing recommendations of the COBRE External Advisory Committee. Disputes arising in the course of COBRE activities will be adjudicated by the Board through consensus or majority vote, as appropriate. The COBRE Director will be ultimately responsible for implementing decisions of the Board. Meetings of the COBRE Executive Board will be held twice yearly. In addition, Board members will be invited to the annual COBRE External Advisory Committee meeting.
COBRE Executive Board members (listed below) have been selected for their experience in program oversight and evaluation.
Richard Yanagihara, M.D.
Chairman
Director, Pacific Center for Emerging Infectious Diseases Research
Professor, Department of Pediatrics, John A. Burns School of Medicine
David Easa, M.D.
Program Director, RCMI Clinical Research Center
Principal Investigator, Center of Clinical Research Excellence
Duane J. Gubler, Sc.D.
Director, Asia-Pacific Institute of Tropical Medicine and Infectious Diseases
Carl-Wilhelm Vogel, M.D., Ph.D.
Director, Cancer Research Center of Hawaii